Detalles de la búsqueda
1.
Assessing HER2 amplification in breast cancer: findings from the Australian In Situ Hybridization Program.
Breast Cancer Res Treat
; 134(2): 617-24, 2012 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-22678156
2.
The International Academy of Cytology Yokohama System for Reporting Breast Fine Needle Aspiration Biopsy Cytopathology: Analysis and discussion of the response to a web-based survey.
Cancer Cytopathol
; 129(6): 450-459, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33369266
3.
Breast fine needle aspiration biopsy cytology: the potential impact of the International Academy of Cytology Yokohama System for Reporting Breast Fine Needle Aspiration Biopsy Cytopathology and the use of rapid on-site evaluation.
J Am Soc Cytopathol
; 9(2): 103-111, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32044283
4.
The International Academy of Cytology Yokohama System for Reporting Breast Fine-Needle Aspiration Biopsy Cytopathology.
Acta Cytol
; 63(4): 257-273, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31112942
5.
The International Academy of Cytology Yokohama System for Reporting Breast Fine-Needle Aspiration Biopsy Cytopathology: Recent research findings and the future.
Cancer Cytopathol
; 129(11): 847-851, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34029451
6.
Expression of extracellular matrix components versican, chondroitin sulfate, tenascin, and hyaluronan, and their association with disease outcome in node-negative breast cancer.
Clin Cancer Res
; 10(7): 2491-8, 2004 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-15073129
7.
Regulation of stromal versican expression by breast cancer cells and importance to relapse-free survival in patients with node-negative primary breast cancer.
Clin Cancer Res
; 8(4): 1054-60, 2002 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-11948113
8.
The International Academy of Cytology Yokohama System for Reporting Breast Fine Needle Aspiration Biopsy Cytopathology.
Acta Cytol
; 63(4): 255-256, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31137023
9.
Global levels of specific histone modifications and an epigenetic gene signature predict prostate cancer progression and development.
Cancer Epidemiol Biomarkers Prev
; 19(10): 2611-22, 2010 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-20841388
Resultados
1 -
9
de 9
1
Próxima >
>>